These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 23097687)

  • 1. 12-Chemokine gene signature identifies lymph node-like structures in melanoma: potential for patient selection for immunotherapy?
    Messina JL; Fenstermacher DA; Eschrich S; Qu X; Berglund AE; Lloyd MC; Schell MJ; Sondak VK; Weber JS; Mulé JJ
    Sci Rep; 2012; 2():765. PubMed ID: 23097687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tertiary lymphoid structures improve immunotherapy and survival in melanoma.
    Cabrita R; Lauss M; Sanna A; Donia M; Skaarup Larsen M; Mitra S; Johansson I; Phung B; Harbst K; Vallon-Christersson J; van Schoiack A; Lövgren K; Warren S; Jirström K; Olsson H; Pietras K; Ingvar C; Isaksson K; Schadendorf D; Schmidt H; Bastholt L; Carneiro A; Wargo JA; Svane IM; Jönsson G
    Nature; 2020 Jan; 577(7791):561-565. PubMed ID: 31942071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of terminally differentiated tumor-specific CD8+ T cells at tumor site in spite of antitumor immunity to self-antigens in human metastatic melanoma.
    Mortarini R; Piris A; Maurichi A; Molla A; Bersani I; Bono A; Bartoli C; Santinami M; Lombardo C; Ravagnani F; Cascinelli N; Parmiani G; Anichini A
    Cancer Res; 2003 May; 63(10):2535-45. PubMed ID: 12750277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of Chemokines and a CD4-Positive T Cell Subset in the Development of Conjunctival Secondary Lymphoid Follicles in an Atopic Keratoconjunctivitis Mouse Model.
    Shoji J; Nakanishi Y; Ishimori A; Sakimoto T; Inada N; Nemoto N
    Int Arch Allergy Immunol; 2015; 167(3):147-57. PubMed ID: 26302769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation of CD8+ T cells from tumor-invaded and tumor-free lymph nodes of melanoma patients: role of common gamma-chain cytokines.
    Anichini A; Scarito A; Molla A; Parmiani G; Mortarini R
    J Immunol; 2003 Aug; 171(4):2134-41. PubMed ID: 12902520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unique ectopic lymph node-like structures present in human primary colorectal carcinoma are identified by immune gene array profiling.
    Coppola D; Nebozhyn M; Khalil F; Dai H; Yeatman T; Loboda A; Mulé JJ
    Am J Pathol; 2011 Jul; 179(1):37-45. PubMed ID: 21703392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adoptive cellular therapy with tumor vaccine draining lymph node lymphocytes after vaccination with HLA-B7/beta2-microglobulin gene-modified autologous tumor cells.
    Meijer SL; Dols A; Urba WJ; Hu HM; Smith II JW; Vetto J; Wood W; Doran T; Chu Y; Sayaharuban P; Alvord WG; Fox BA
    J Immunother; 2002; 25(4):359-72. PubMed ID: 12142559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved four-color flow cytometry method using fluo-3 and triple immunofluorescence for analysis of intracellular calcium ion ([Ca2+]i) fluxes among mouse lymph node B- and T-lymphocyte subsets.
    Greimers R; Trebak M; Moutschen M; Jacobs N; Boniver J
    Cytometry; 1996 Mar; 23(3):205-17. PubMed ID: 8974866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV type 1-reactive chemokine-producing CD8+ and CD4+ cells expanded from infected lymph nodes.
    Triozzi PL; Bresler HS; Aldrich WA
    AIDS Res Hum Retroviruses; 1998 May; 14(8):643-9. PubMed ID: 9618075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of the expression of chemokines and their receptors in regional lymph nodes of melanoma patients.
    Xiong TF; Pan FQ; Liang Q; Luo R; Li D; Mo H; Zhou X
    J Cell Mol Med; 2020 Mar; 24(6):3407-3418. PubMed ID: 31983065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative analysis of transcriptional profiling of CD3+, CD4+ and CD8+ T cells identifies novel immune response players in T-cell activation.
    Wang M; Windgassen D; Papoutsakis ET
    BMC Genomics; 2008 May; 9():225. PubMed ID: 18485203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyfunctional response by ImmTAC (IMCgp100) redirected CD8
    Boudousquie C; Bossi G; Hurst JM; Rygiel KA; Jakobsen BK; Hassan NJ
    Immunology; 2017 Nov; 152(3):425-438. PubMed ID: 28640942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intratumoral interferon-gamma increases chemokine production but fails to increase T cell infiltration of human melanoma metastases.
    Mauldin IS; Wages NA; Stowman AM; Wang E; Smolkin ME; Olson WC; Deacon DH; Smith KT; Galeassi NV; Chianese-Bullock KA; Dengel LT; Marincola FM; Petroni GR; Mullins DW; Slingluff CL
    Cancer Immunol Immunother; 2016 Oct; 65(10):1189-99. PubMed ID: 27522581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4
    Di Gennaro P; Gerlini G; Urso C; Sestini S; Brandani P; Pimpinelli N; Borgognoni L
    Clin Exp Metastasis; 2016 Dec; 33(8):787-798. PubMed ID: 27475809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of activation-related molecules on regional lymph node lymphocytes in human lung cancer.
    Takenoyama M; Yasumoto K; Harada M; Matsuzaki G; Ishida T; Sugimachi K; Nomoto K
    Immunobiology; 1996 Jul; 195(2):140-51. PubMed ID: 8877391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Melanoma-reactive CD4+ T-Cell Subsets From Human Melanoma Draining Lymph Nodes.
    Zhang M; Graor H; Yan L; Kim J
    J Immunother; 2016 Jan; 39(1):15-26. PubMed ID: 26641258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination with mRNA-electroporated dendritic cells induces robust tumor antigen-specific CD4+ and CD8+ T cells responses in stage III and IV melanoma patients.
    Aarntzen EH; Schreibelt G; Bol K; Lesterhuis WJ; Croockewit AJ; de Wilt JH; van Rossum MM; Blokx WA; Jacobs JF; Duiveman-de Boer T; Schuurhuis DH; Mus R; Thielemans K; de Vries IJ; Figdor CG; Punt CJ; Adema GJ
    Clin Cancer Res; 2012 Oct; 18(19):5460-70. PubMed ID: 22896657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous melanoma vaccine induces antitumor and self-reactive immune responses that affect patient survival and depend on MHC class II expression on vaccine cells.
    Lotem M; Machlenkin A; Hamburger T; Nissan A; Kadouri L; Frankenburg S; Gimmon Z; Elias O; David IB; Kuznetz A; Shiloni E; Peretz T
    Clin Cancer Res; 2009 Aug; 15(15):4968-77. PubMed ID: 19602547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of immune cells in head and neck cancer: CD8+ T-cells and CD20+ B-cells in metastatic lymph nodes are associated with favourable outcome in patients with oro- and hypopharyngeal carcinoma.
    Pretscher D; Distel LV; Grabenbauer GG; Wittlinger M; Buettner M; Niedobitek G
    BMC Cancer; 2009 Aug; 9():292. PubMed ID: 19698134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and Validation of a CD8+ T Cell Infiltration-Related Signature for Melanoma Patients.
    Yuan Y; Zhu Z; Lan Y; Duan S; Zhu Z; Zhang X; Li G; Qu H; Feng Y; Cai H; Song Z
    Front Immunol; 2021; 12():659444. PubMed ID: 34040608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.